Arshad Rahman
YOU?
Author Swipe
View article: A critical role of the Erk1/2 downstream targets c-Fos, Egr-1, and Egr-2 in PU.1-driven monocyte development
A critical role of the Erk1/2 downstream targets c-Fos, Egr-1, and Egr-2 in PU.1-driven monocyte development Open
The Ets family transcription factor PU.1 plays multiple roles in hematopoiesis. PU.1 acts in a graded manner to regulate myeloid and lymphoid development with high expression levels promoting monopoiesis and low expression levels instructi…
View article: Occludin Is Essential to Maintain Normal Alveolar Barrier Integrity and Its Protective Role During ARDS Progression
Occludin Is Essential to Maintain Normal Alveolar Barrier Integrity and Its Protective Role During ARDS Progression Open
Acute respiratory distress syndrome (ARDS) is a severe lung condition without targeted therapy that is characterized by the disruption of epithelial and endothelial barriers. The role of the tight junction protein occludin in the pathogene…
View article: Bovine Pericardium Scaffold as a Critical Tool for Cardiac Surgery with Mesenchymal Stem Cell Seeding : A Narrative Review
Bovine Pericardium Scaffold as a Critical Tool for Cardiac Surgery with Mesenchymal Stem Cell Seeding : A Narrative Review Open
This review explores the significance of pericardial dissection in cardiac surgery for managing congenital heart disease (CHD). The procedure often results in intrapericardial adhesion formation, impacting outcomes and increasing hospitali…
View article: Impact of Peptide Sequence on Functional siRNA Delivery and Gene Knockdown with Cyclic Amphipathic Peptide Delivery Agents
Impact of Peptide Sequence on Functional siRNA Delivery and Gene Knockdown with Cyclic Amphipathic Peptide Delivery Agents Open
Short-interfering RNA (siRNA) oligonucleotide therapeutics that modify gene expression by accessing RNA-interference (RNAi) pathways have great promise for the treatment of a range of disorders; however, their application in clinical setti…
View article: Supplementary Methods from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression
Supplementary Methods from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression Open
Supplementary Methods from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression
View article: Supplementary Figure 1 from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression
Supplementary Figure 1 from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression Open
Supplementary Figure 1 from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression
View article: Supplementary Figure 9 from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression
Supplementary Figure 9 from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression Open
Supplementary Figure 9 from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression
View article: Supplementary Figure 1 from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression
Supplementary Figure 1 from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression Open
Supplementary Figure 1 from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression
View article: Supplementary Figures 2-5 from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression
Supplementary Figures 2-5 from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression Open
Supplementary Figures 2-5 from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression
View article: Supplementary Figure Legends 1-10 from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression
Supplementary Figure Legends 1-10 from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression Open
Supplementary Figure Legends 1-10 from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression
View article: Supplementary Figure 6 from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression
Supplementary Figure 6 from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression Open
Supplementary Figure 6 from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression
View article: Supplementary Figure 8 from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression
Supplementary Figure 8 from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression Open
Supplementary Figure 8 from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression
View article: Supplementary Figure Legends 1-10 from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression
Supplementary Figure Legends 1-10 from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression Open
Supplementary Figure Legends 1-10 from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression
View article: Data from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression
Data from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression Open
Angiogenesis is a critical step during cancer progression. The VEGF is a major stimulator for angiogenesis and is predominantly contributed by cancer cells in tumors. Inhibition of the VEGF signaling pathway has shown promising therapeutic…
View article: Supplementary Figure 9 from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression
Supplementary Figure 9 from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression Open
Supplementary Figure 9 from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression
View article: Data from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression
Data from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression Open
Angiogenesis is a critical step during cancer progression. The VEGF is a major stimulator for angiogenesis and is predominantly contributed by cancer cells in tumors. Inhibition of the VEGF signaling pathway has shown promising therapeutic…
View article: Supplementary Figure 10 from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression
Supplementary Figure 10 from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression Open
Supplementary Figure 10 from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression
View article: Supplementary Figure 10 from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression
Supplementary Figure 10 from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression Open
Supplementary Figure 10 from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression
View article: Supplementary Figures 2-5 from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression
Supplementary Figures 2-5 from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression Open
Supplementary Figures 2-5 from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression
View article: Supplementary Figure 8 from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression
Supplementary Figure 8 from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression Open
Supplementary Figure 8 from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression
View article: Supplementary Figure 6 from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression
Supplementary Figure 6 from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression Open
Supplementary Figure 6 from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression
View article: Supplementary Figure 7 from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression
Supplementary Figure 7 from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression Open
Supplementary Figure 7 from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression
View article: Supplementary Figure 7 from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression
Supplementary Figure 7 from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression Open
Supplementary Figure 7 from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression
View article: Supplementary Methods from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression
Supplementary Methods from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression Open
Supplementary Methods from GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression
View article: Therapeutic Targeting of NF-κB in Acute Lung Injury: A Double-Edged Sword
Therapeutic Targeting of NF-κB in Acute Lung Injury: A Double-Edged Sword Open
Acute lung injury/acute respiratory distress syndrome (ALI/ARDS) is a devastating disease that can be caused by a variety of conditions including pneumonia, sepsis, trauma, and most recently, COVID-19. Although our understanding of the mec…
View article: Essential Role of Rho-Associated Kinase in ABO Immune Complex-Mediated Endothelial Barrier Disruption
Essential Role of Rho-Associated Kinase in ABO Immune Complex-Mediated Endothelial Barrier Disruption Open
ABO immune complexes (ABO-IC) formed by ABO-incompatible antigen-antibody interaction are associated with hemolysis and platelet destruction in patients transfused with ABO-nonidentical blood products. However, the effects of ABO-IC on end…
View article: Phosphodiesterase 10A Is a Key Mediator of Lung Inflammation
Phosphodiesterase 10A Is a Key Mediator of Lung Inflammation Open
Cyclic nucleotides cAMP and cGMP are important regulators of immune cell functions. Phosphodiesterases (PDEs) hydrolyze cAMP and/or cGMP and, thus, play crucial roles in cyclic nucleotide homeostasis. Abnormal alterations of PDE expression…